English
简体中文
Total: £ 56.28
Published Date: 2025-05-02 | Pages: 92 | Tables: 93 | Medical Care
The global market for Monoclonal Antibody Discovery Platform was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Monoclonal antibodies are antibodies secreted by a single B lymphocyte clone. Since B lymphocytes can only produce a proprietary antibody against one antigenic determinant, they have highly specific physical and chemical properties, single biological activity, and Antigen binding specificity and other characteristics. After more than 30 years of research and development, monoclonal antibody drugs have made great progress in the treatment of tumors and autoimmune diseases. They are also the fastest growing and most promising development direction in the pharmaceutical field. This report studies the monoclonal antibody drug discovery platform market.
North American market for Monoclonal Antibody Discovery Platform is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Monoclonal Antibody Discovery Platform is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Monoclonal Antibody Discovery Platform in Biomedical Research is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Monoclonal Antibody Discovery Platform include Sartorius, Trianni (AbCellera), Biocytogen, Abveris, Creative Biolabs, Integral Molecular, GigaGen, Creative Biolabs, AvantBunny, MAB Discovery (BioNTech), etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Monoclonal Antibody Discovery Platform, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Monoclonal Antibody Discovery Platform.
The Monoclonal Antibody Discovery Platform market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Monoclonal Antibody Discovery Platform market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Monoclonal Antibody Discovery Platform companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sartorius
Trianni (AbCellera)
Biocytogen
Abveris
Creative Biolabs
Integral Molecular
GigaGen
Creative Biolabs
AvantBunny
MAB Discovery (BioNTech)
Shanghai Fosun Pharmaceutical (Group)
WuXi Biologics
Lepu Biopharma
Harbour BioMed
3SBio Group
SAFE Pharmaceutical Technology
Segment by Type
FACS (Fluorescent Activated Cell Sorting)
LCM (Laser-Capture Microdissection)
Microengraving
Droplet Microfluidics
Other
Segment by Application
Biomedical Research
Disease Diagnosis and Treatment
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Monoclonal Antibody Discovery Platform company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Monoclonal Antibody Discovery Platform Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 FACS (Fluorescent Activated Cell Sorting)
1.2.3 LCM (Laser-Capture Microdissection)
1.2.4 Microengraving
1.2.5 Droplet Microfluidics
1.2.6 Other
1.3 Market by Application
1.3.1 Global Monoclonal Antibody Discovery Platform Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Biomedical Research
1.3.3 Disease Diagnosis and Treatment
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Monoclonal Antibody Discovery Platform Market Perspective (2020-2031)
2.2 Global Monoclonal Antibody Discovery Platform Growth Trends by Region
2.2.1 Global Monoclonal Antibody Discovery Platform Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Monoclonal Antibody Discovery Platform Historic Market Size by Region (2020-2025)
2.2.3 Monoclonal Antibody Discovery Platform Forecasted Market Size by Region (2026-2031)
2.3 Monoclonal Antibody Discovery Platform Market Dynamics
2.3.1 Monoclonal Antibody Discovery Platform Industry Trends
2.3.2 Monoclonal Antibody Discovery Platform Market Drivers
2.3.3 Monoclonal Antibody Discovery Platform Market Challenges
2.3.4 Monoclonal Antibody Discovery Platform Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Monoclonal Antibody Discovery Platform Players by Revenue
3.1.1 Global Top Monoclonal Antibody Discovery Platform Players by Revenue (2020-2025)
3.1.2 Global Monoclonal Antibody Discovery Platform Revenue Market Share by Players (2020-2025)
3.2 Global Monoclonal Antibody Discovery Platform Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Monoclonal Antibody Discovery Platform Revenue
3.4 Global Monoclonal Antibody Discovery Platform Market Concentration Ratio
3.4.1 Global Monoclonal Antibody Discovery Platform Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Monoclonal Antibody Discovery Platform Revenue in 2024
3.5 Global Key Players of Monoclonal Antibody Discovery Platform Head office and Area Served
3.6 Global Key Players of Monoclonal Antibody Discovery Platform, Product and Application
3.7 Global Key Players of Monoclonal Antibody Discovery Platform, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Monoclonal Antibody Discovery Platform Breakdown Data by Type
4.1 Global Monoclonal Antibody Discovery Platform Historic Market Size by Type (2020-2025)
4.2 Global Monoclonal Antibody Discovery Platform Forecasted Market Size by Type (2026-2031)
5 Monoclonal Antibody Discovery Platform Breakdown Data by Application
5.1 Global Monoclonal Antibody Discovery Platform Historic Market Size by Application (2020-2025)
5.2 Global Monoclonal Antibody Discovery Platform Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Monoclonal Antibody Discovery Platform Market Size (2020-2031)
6.2 North America Monoclonal Antibody Discovery Platform Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Monoclonal Antibody Discovery Platform Market Size by Country (2020-2025)
6.4 North America Monoclonal Antibody Discovery Platform Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Monoclonal Antibody Discovery Platform Market Size (2020-2031)
7.2 Europe Monoclonal Antibody Discovery Platform Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Monoclonal Antibody Discovery Platform Market Size by Country (2020-2025)
7.4 Europe Monoclonal Antibody Discovery Platform Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Monoclonal Antibody Discovery Platform Market Size (2020-2031)
8.2 Asia-Pacific Monoclonal Antibody Discovery Platform Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Monoclonal Antibody Discovery Platform Market Size by Region (2020-2025)
8.4 Asia-Pacific Monoclonal Antibody Discovery Platform Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Monoclonal Antibody Discovery Platform Market Size (2020-2031)
9.2 Latin America Monoclonal Antibody Discovery Platform Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Monoclonal Antibody Discovery Platform Market Size by Country (2020-2025)
9.4 Latin America Monoclonal Antibody Discovery Platform Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Monoclonal Antibody Discovery Platform Market Size (2020-2031)
10.2 Middle East & Africa Monoclonal Antibody Discovery Platform Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Monoclonal Antibody Discovery Platform Market Size by Country (2020-2025)
10.4 Middle East & Africa Monoclonal Antibody Discovery Platform Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sartorius
11.1.1 Sartorius Company Details
11.1.2 Sartorius Business Overview
11.1.3 Sartorius Monoclonal Antibody Discovery Platform Introduction
11.1.4 Sartorius Revenue in Monoclonal Antibody Discovery Platform Business (2020-2025)
11.1.5 Sartorius Recent Development
11.2 Trianni (AbCellera)
11.2.1 Trianni (AbCellera) Company Details
11.2.2 Trianni (AbCellera) Business Overview
11.2.3 Trianni (AbCellera) Monoclonal Antibody Discovery Platform Introduction
11.2.4 Trianni (AbCellera) Revenue in Monoclonal Antibody Discovery Platform Business (2020-2025)
11.2.5 Trianni (AbCellera) Recent Development
11.3 Biocytogen
11.3.1 Biocytogen Company Details
11.3.2 Biocytogen Business Overview
11.3.3 Biocytogen Monoclonal Antibody Discovery Platform Introduction
11.3.4 Biocytogen Revenue in Monoclonal Antibody Discovery Platform Business (2020-2025)
11.3.5 Biocytogen Recent Development
11.4 Abveris
11.4.1 Abveris Company Details
11.4.2 Abveris Business Overview
11.4.3 Abveris Monoclonal Antibody Discovery Platform Introduction
11.4.4 Abveris Revenue in Monoclonal Antibody Discovery Platform Business (2020-2025)
11.4.5 Abveris Recent Development
11.5 Creative Biolabs
11.5.1 Creative Biolabs Company Details
11.5.2 Creative Biolabs Business Overview
11.5.3 Creative Biolabs Monoclonal Antibody Discovery Platform Introduction
11.5.4 Creative Biolabs Revenue in Monoclonal Antibody Discovery Platform Business (2020-2025)
11.5.5 Creative Biolabs Recent Development
11.6 Integral Molecular
11.6.1 Integral Molecular Company Details
11.6.2 Integral Molecular Business Overview
11.6.3 Integral Molecular Monoclonal Antibody Discovery Platform Introduction
11.6.4 Integral Molecular Revenue in Monoclonal Antibody Discovery Platform Business (2020-2025)
11.6.5 Integral Molecular Recent Development
11.7 GigaGen
11.7.1 GigaGen Company Details
11.7.2 GigaGen Business Overview
11.7.3 GigaGen Monoclonal Antibody Discovery Platform Introduction
11.7.4 GigaGen Revenue in Monoclonal Antibody Discovery Platform Business (2020-2025)
11.7.5 GigaGen Recent Development
11.8 Creative Biolabs
11.8.1 Creative Biolabs Company Details
11.8.2 Creative Biolabs Business Overview
11.8.3 Creative Biolabs Monoclonal Antibody Discovery Platform Introduction
11.8.4 Creative Biolabs Revenue in Monoclonal Antibody Discovery Platform Business (2020-2025)
11.8.5 Creative Biolabs Recent Development
11.9 AvantBunny
11.9.1 AvantBunny Company Details
11.9.2 AvantBunny Business Overview
11.9.3 AvantBunny Monoclonal Antibody Discovery Platform Introduction
11.9.4 AvantBunny Revenue in Monoclonal Antibody Discovery Platform Business (2020-2025)
11.9.5 AvantBunny Recent Development
11.10 MAB Discovery (BioNTech)
11.10.1 MAB Discovery (BioNTech) Company Details
11.10.2 MAB Discovery (BioNTech) Business Overview
11.10.3 MAB Discovery (BioNTech) Monoclonal Antibody Discovery Platform Introduction
11.10.4 MAB Discovery (BioNTech) Revenue in Monoclonal Antibody Discovery Platform Business (2020-2025)
11.10.5 MAB Discovery (BioNTech) Recent Development
11.11 Shanghai Fosun Pharmaceutical (Group)
11.11.1 Shanghai Fosun Pharmaceutical (Group) Company Details
11.11.2 Shanghai Fosun Pharmaceutical (Group) Business Overview
11.11.3 Shanghai Fosun Pharmaceutical (Group) Monoclonal Antibody Discovery Platform Introduction
11.11.4 Shanghai Fosun Pharmaceutical (Group) Revenue in Monoclonal Antibody Discovery Platform Business (2020-2025)
11.11.5 Shanghai Fosun Pharmaceutical (Group) Recent Development
11.12 WuXi Biologics
11.12.1 WuXi Biologics Company Details
11.12.2 WuXi Biologics Business Overview
11.12.3 WuXi Biologics Monoclonal Antibody Discovery Platform Introduction
11.12.4 WuXi Biologics Revenue in Monoclonal Antibody Discovery Platform Business (2020-2025)
11.12.5 WuXi Biologics Recent Development
11.13 Lepu Biopharma
11.13.1 Lepu Biopharma Company Details
11.13.2 Lepu Biopharma Business Overview
11.13.3 Lepu Biopharma Monoclonal Antibody Discovery Platform Introduction
11.13.4 Lepu Biopharma Revenue in Monoclonal Antibody Discovery Platform Business (2020-2025)
11.13.5 Lepu Biopharma Recent Development
11.14 Harbour BioMed
11.14.1 Harbour BioMed Company Details
11.14.2 Harbour BioMed Business Overview
11.14.3 Harbour BioMed Monoclonal Antibody Discovery Platform Introduction
11.14.4 Harbour BioMed Revenue in Monoclonal Antibody Discovery Platform Business (2020-2025)
11.14.5 Harbour BioMed Recent Development
11.15 3SBio Group
11.15.1 3SBio Group Company Details
11.15.2 3SBio Group Business Overview
11.15.3 3SBio Group Monoclonal Antibody Discovery Platform Introduction
11.15.4 3SBio Group Revenue in Monoclonal Antibody Discovery Platform Business (2020-2025)
11.15.5 3SBio Group Recent Development
11.16 SAFE Pharmaceutical Technology
11.16.1 SAFE Pharmaceutical Technology Company Details
11.16.2 SAFE Pharmaceutical Technology Business Overview
11.16.3 SAFE Pharmaceutical Technology Monoclonal Antibody Discovery Platform Introduction
11.16.4 SAFE Pharmaceutical Technology Revenue in Monoclonal Antibody Discovery Platform Business (2020-2025)
11.16.5 SAFE Pharmaceutical Technology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Monoclonal Antibody Discovery Platform Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of FACS (Fluorescent Activated Cell Sorting)
Table 3. Key Players of LCM (Laser-Capture Microdissection)
Table 4. Key Players of Microengraving
Table 5. Key Players of Droplet Microfluidics
Table 6. Key Players of Other
Table 7. Global Monoclonal Antibody Discovery Platform Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Monoclonal Antibody Discovery Platform Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Monoclonal Antibody Discovery Platform Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Monoclonal Antibody Discovery Platform Market Share by Region (2020-2025)
Table 11. Global Monoclonal Antibody Discovery Platform Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Monoclonal Antibody Discovery Platform Market Share by Region (2026-2031)
Table 13. Monoclonal Antibody Discovery Platform Market Trends
Table 14. Monoclonal Antibody Discovery Platform Market Drivers
Table 15. Monoclonal Antibody Discovery Platform Market Challenges
Table 16. Monoclonal Antibody Discovery Platform Market Restraints
Table 17. Global Monoclonal Antibody Discovery Platform Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Monoclonal Antibody Discovery Platform Market Share by Players (2020-2025)
Table 19. Global Top Monoclonal Antibody Discovery Platform Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal Antibody Discovery Platform as of 2024)
Table 20. Ranking of Global Top Monoclonal Antibody Discovery Platform Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Monoclonal Antibody Discovery Platform Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Monoclonal Antibody Discovery Platform, Headquarters and Area Served
Table 23. Global Key Players of Monoclonal Antibody Discovery Platform, Product and Application
Table 24. Global Key Players of Monoclonal Antibody Discovery Platform, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Monoclonal Antibody Discovery Platform Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Monoclonal Antibody Discovery Platform Revenue Market Share by Type (2020-2025)
Table 28. Global Monoclonal Antibody Discovery Platform Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Monoclonal Antibody Discovery Platform Revenue Market Share by Type (2026-2031)
Table 30. Global Monoclonal Antibody Discovery Platform Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Monoclonal Antibody Discovery Platform Revenue Market Share by Application (2020-2025)
Table 32. Global Monoclonal Antibody Discovery Platform Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Monoclonal Antibody Discovery Platform Revenue Market Share by Application (2026-2031)
Table 34. North America Monoclonal Antibody Discovery Platform Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Monoclonal Antibody Discovery Platform Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Monoclonal Antibody Discovery Platform Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Monoclonal Antibody Discovery Platform Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Monoclonal Antibody Discovery Platform Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Monoclonal Antibody Discovery Platform Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Monoclonal Antibody Discovery Platform Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Monoclonal Antibody Discovery Platform Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Monoclonal Antibody Discovery Platform Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Monoclonal Antibody Discovery Platform Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Monoclonal Antibody Discovery Platform Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Monoclonal Antibody Discovery Platform Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Monoclonal Antibody Discovery Platform Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Monoclonal Antibody Discovery Platform Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Monoclonal Antibody Discovery Platform Market Size by Country (2026-2031) & (US$ Million)
Table 49. Sartorius Company Details
Table 50. Sartorius Business Overview
Table 51. Sartorius Monoclonal Antibody Discovery Platform Product
Table 52. Sartorius Revenue in Monoclonal Antibody Discovery Platform Business (2020-2025) & (US$ Million)
Table 53. Sartorius Recent Development
Table 54. Trianni (AbCellera) Company Details
Table 55. Trianni (AbCellera) Business Overview
Table 56. Trianni (AbCellera) Monoclonal Antibody Discovery Platform Product
Table 57. Trianni (AbCellera) Revenue in Monoclonal Antibody Discovery Platform Business (2020-2025) & (US$ Million)
Table 58. Trianni (AbCellera) Recent Development
Table 59. Biocytogen Company Details
Table 60. Biocytogen Business Overview
Table 61. Biocytogen Monoclonal Antibody Discovery Platform Product
Table 62. Biocytogen Revenue in Monoclonal Antibody Discovery Platform Business (2020-2025) & (US$ Million)
Table 63. Biocytogen Recent Development
Table 64. Abveris Company Details
Table 65. Abveris Business Overview
Table 66. Abveris Monoclonal Antibody Discovery Platform Product
Table 67. Abveris Revenue in Monoclonal Antibody Discovery Platform Business (2020-2025) & (US$ Million)
Table 68. Abveris Recent Development
Table 69. Creative Biolabs Company Details
Table 70. Creative Biolabs Business Overview
Table 71. Creative Biolabs Monoclonal Antibody Discovery Platform Product
Table 72. Creative Biolabs Revenue in Monoclonal Antibody Discovery Platform Business (2020-2025) & (US$ Million)
Table 73. Creative Biolabs Recent Development
Table 74. Integral Molecular Company Details
Table 75. Integral Molecular Business Overview
Table 76. Integral Molecular Monoclonal Antibody Discovery Platform Product
Table 77. Integral Molecular Revenue in Monoclonal Antibody Discovery Platform Business (2020-2025) & (US$ Million)
Table 78. Integral Molecular Recent Development
Table 79. GigaGen Company Details
Table 80. GigaGen Business Overview
Table 81. GigaGen Monoclonal Antibody Discovery Platform Product
Table 82. GigaGen Revenue in Monoclonal Antibody Discovery Platform Business (2020-2025) & (US$ Million)
Table 83. GigaGen Recent Development
Table 84. Creative Biolabs Company Details
Table 85. Creative Biolabs Business Overview
Table 86. Creative Biolabs Monoclonal Antibody Discovery Platform Product
Table 87. Creative Biolabs Revenue in Monoclonal Antibody Discovery Platform Business (2020-2025) & (US$ Million)
Table 88. Creative Biolabs Recent Development
Table 89. AvantBunny Company Details
Table 90. AvantBunny Business Overview
Table 91. AvantBunny Monoclonal Antibody Discovery Platform Product
Table 92. AvantBunny Revenue in Monoclonal Antibody Discovery Platform Business (2020-2025) & (US$ Million)
Table 93. AvantBunny Recent Development
Table 94. MAB Discovery (BioNTech) Company Details
Table 95. MAB Discovery (BioNTech) Business Overview
Table 96. MAB Discovery (BioNTech) Monoclonal Antibody Discovery Platform Product
Table 97. MAB Discovery (BioNTech) Revenue in Monoclonal Antibody Discovery Platform Business (2020-2025) & (US$ Million)
Table 98. MAB Discovery (BioNTech) Recent Development
Table 99. Shanghai Fosun Pharmaceutical (Group) Company Details
Table 100. Shanghai Fosun Pharmaceutical (Group) Business Overview
Table 101. Shanghai Fosun Pharmaceutical (Group) Monoclonal Antibody Discovery Platform Product
Table 102. Shanghai Fosun Pharmaceutical (Group) Revenue in Monoclonal Antibody Discovery Platform Business (2020-2025) & (US$ Million)
Table 103. Shanghai Fosun Pharmaceutical (Group) Recent Development
Table 104. WuXi Biologics Company Details
Table 105. WuXi Biologics Business Overview
Table 106. WuXi Biologics Monoclonal Antibody Discovery Platform Product
Table 107. WuXi Biologics Revenue in Monoclonal Antibody Discovery Platform Business (2020-2025) & (US$ Million)
Table 108. WuXi Biologics Recent Development
Table 109. Lepu Biopharma Company Details
Table 110. Lepu Biopharma Business Overview
Table 111. Lepu Biopharma Monoclonal Antibody Discovery Platform Product
Table 112. Lepu Biopharma Revenue in Monoclonal Antibody Discovery Platform Business (2020-2025) & (US$ Million)
Table 113. Lepu Biopharma Recent Development
Table 114. Harbour BioMed Company Details
Table 115. Harbour BioMed Business Overview
Table 116. Harbour BioMed Monoclonal Antibody Discovery Platform Product
Table 117. Harbour BioMed Revenue in Monoclonal Antibody Discovery Platform Business (2020-2025) & (US$ Million)
Table 118. Harbour BioMed Recent Development
Table 119. 3SBio Group Company Details
Table 120. 3SBio Group Business Overview
Table 121. 3SBio Group Monoclonal Antibody Discovery Platform Product
Table 122. 3SBio Group Revenue in Monoclonal Antibody Discovery Platform Business (2020-2025) & (US$ Million)
Table 123. 3SBio Group Recent Development
Table 124. SAFE Pharmaceutical Technology Company Details
Table 125. SAFE Pharmaceutical Technology Business Overview
Table 126. SAFE Pharmaceutical Technology Monoclonal Antibody Discovery Platform Product
Table 127. SAFE Pharmaceutical Technology Revenue in Monoclonal Antibody Discovery Platform Business (2020-2025) & (US$ Million)
Table 128. SAFE Pharmaceutical Technology Recent Development
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
Table 132. Authors List of This Report
List of Figures
Figure 1. Monoclonal Antibody Discovery Platform Picture
Figure 2. Global Monoclonal Antibody Discovery Platform Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Monoclonal Antibody Discovery Platform Market Share by Type: 2024 VS 2031
Figure 4. FACS (Fluorescent Activated Cell Sorting) Features
Figure 5. LCM (Laser-Capture Microdissection) Features
Figure 6. Microengraving Features
Figure 7. Droplet Microfluidics Features
Figure 8. Other Features
Figure 9. Global Monoclonal Antibody Discovery Platform Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Monoclonal Antibody Discovery Platform Market Share by Application: 2024 VS 2031
Figure 11. Biomedical Research Case Studies
Figure 12. Disease Diagnosis and Treatment Case Studies
Figure 13. Other Case Studies
Figure 14. Monoclonal Antibody Discovery Platform Report Years Considered
Figure 15. Global Monoclonal Antibody Discovery Platform Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Monoclonal Antibody Discovery Platform Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Monoclonal Antibody Discovery Platform Market Share by Region: 2024 VS 2031
Figure 18. Global Monoclonal Antibody Discovery Platform Market Share by Players in 2024
Figure 19. Global Top Monoclonal Antibody Discovery Platform Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal Antibody Discovery Platform as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Monoclonal Antibody Discovery Platform Revenue in 2024
Figure 21. North America Monoclonal Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Monoclonal Antibody Discovery Platform Market Share by Country (2020-2031)
Figure 23. United States Monoclonal Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Monoclonal Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Monoclonal Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Monoclonal Antibody Discovery Platform Market Share by Country (2020-2031)
Figure 27. Germany Monoclonal Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Monoclonal Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Monoclonal Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Monoclonal Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Monoclonal Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Monoclonal Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Monoclonal Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Monoclonal Antibody Discovery Platform Market Share by Region (2020-2031)
Figure 35. China Monoclonal Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Monoclonal Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Monoclonal Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Monoclonal Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Monoclonal Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Monoclonal Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Monoclonal Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Monoclonal Antibody Discovery Platform Market Share by Country (2020-2031)
Figure 43. Mexico Monoclonal Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Monoclonal Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Monoclonal Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Monoclonal Antibody Discovery Platform Market Share by Country (2020-2031)
Figure 47. Turkey Monoclonal Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Monoclonal Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Monoclonal Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Sartorius Revenue Growth Rate in Monoclonal Antibody Discovery Platform Business (2020-2025)
Figure 51. Trianni (AbCellera) Revenue Growth Rate in Monoclonal Antibody Discovery Platform Business (2020-2025)
Figure 52. Biocytogen Revenue Growth Rate in Monoclonal Antibody Discovery Platform Business (2020-2025)
Figure 53. Abveris Revenue Growth Rate in Monoclonal Antibody Discovery Platform Business (2020-2025)
Figure 54. Creative Biolabs Revenue Growth Rate in Monoclonal Antibody Discovery Platform Business (2020-2025)
Figure 55. Integral Molecular Revenue Growth Rate in Monoclonal Antibody Discovery Platform Business (2020-2025)
Figure 56. GigaGen Revenue Growth Rate in Monoclonal Antibody Discovery Platform Business (2020-2025)
Figure 57. Creative Biolabs Revenue Growth Rate in Monoclonal Antibody Discovery Platform Business (2020-2025)
Figure 58. AvantBunny Revenue Growth Rate in Monoclonal Antibody Discovery Platform Business (2020-2025)
Figure 59. MAB Discovery (BioNTech) Revenue Growth Rate in Monoclonal Antibody Discovery Platform Business (2020-2025)
Figure 60. Shanghai Fosun Pharmaceutical (Group) Revenue Growth Rate in Monoclonal Antibody Discovery Platform Business (2020-2025)
Figure 61. WuXi Biologics Revenue Growth Rate in Monoclonal Antibody Discovery Platform Business (2020-2025)
Figure 62. Lepu Biopharma Revenue Growth Rate in Monoclonal Antibody Discovery Platform Business (2020-2025)
Figure 63. Harbour BioMed Revenue Growth Rate in Monoclonal Antibody Discovery Platform Business (2020-2025)
Figure 64. 3SBio Group Revenue Growth Rate in Monoclonal Antibody Discovery Platform Business (2020-2025)
Figure 65. SAFE Pharmaceutical Technology Revenue Growth Rate in Monoclonal Antibody Discovery Platform Business (2020-2025)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
